Current and Emerging Therapeutic Strategies for the Treatment of Meibomian Gland Dysfunction (MGD)

被引:102
|
作者
Thode, Adam R. [1 ]
Latkany, Robert A. [1 ]
机构
[1] New York Eye & Ear Infirm Mt Sinai, New York, NY 10003 USA
关键词
POLYUNSATURATED FATTY-ACIDS; DRY EYE; LIPID LAYER; DIETARY SUPPLEMENTATION; AZITHROMYCIN; EFFICACY; CLASSIFICATION; 0.05-PERCENT; MINOCYCLINE; CYTOKINES;
D O I
10.1007/s40265-015-0432-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Meibomian gland (MG) dysfunction (MGD) is a multifactorial, chronic condition of the eyelids, leading to eye irritation, inflammation and ocular surface disease. Initial conservative therapy often includes a combination of warm compresses in addition to baby shampoo or eyelid wipes. The practice of lid hygiene dates back to the 1950s, when selenium sulfide-based shampoo was first used to treat seborrhoeic dermatitis of the eyelids. Today, tear-free baby shampoo has replaced dandruff shampoo for MGD treatment and offers symptom relief in selected patients. However, many will not achieve significant improvement on this therapy alone; some may even develop an allergy to the added dyes and fragrances in these products. Other manual and mechanical techniques to treat MGD include MG expression and massage, MG probing and LipiFlow (R). While potentially effective in patients with moderate MGD, these procedures are more invasive and may be cost prohibitive. Pharmacological treatments are another course of action. Supplements rich in omega-3 fatty acids have been shown to improve both MGD and dry eye symptoms. Tea tree oil, specifically the terpenin-4-ol component, is especially effective in treating MGD associated with Demodex mites. Topical antibiotics, such as azithromycin, or systemic antibiotics, such as doxycycline or azithromycin, can improve MGD symptoms both by altering the ocular flora and through anti-inflammatory mechanisms. Addressing and treating concurrent ocular allergy is integral to symptom management. Topical N-acetylcysteine and topical cyclosporine can both be effective therapeutic adjuncts in patients with concurrent dry eye. A short course of topical steroid may be used in some severe cases, with monitoring for steroid-induced glaucoma and cataracts. While the standard method to treat MGD is simply warm compresses and baby shampoo, a more tailored approach to address the multiple aetiologies of the disease is suggested.
引用
收藏
页码:1177 / 1185
页数:9
相关论文
共 50 条
  • [41] Conservative treatment of meibomian gland dysfunction.
    Romero, JM
    Perry, HD
    Levinson, DH
    Doshi, S
    Terraciano, A
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S36 - S36
  • [42] Topical Spironolactone in the Treatment of Meibomian Gland Dysfunction
    Renee Johnson, Janell
    Ali, Waju
    Wong, Brian S.
    de Jesus, Mikhail
    Yee, Richard W.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [43] Gold nanoparticles-loaded contact lenses for laser protection and Meibomian Gland Dysfunction (MGD) dry eye treatment
    Liu, Zhen
    Chauhan, Anuj
    COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, 2022, 635
  • [44] The International Workshop on Meibomian Gland Dysfunction: Report of the Subcommittee on the Epidemiology of, and Associated Risk Factors for, MGD
    Schaumberg, Debra A.
    Nichols, Jason J.
    Papas, Eric B.
    Tong, Louis
    Uchino, Miki
    Nichols, Kelly K.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2011, 52 (04) : 1994 - 2005
  • [45] COMPARISON OF MEIBOGRAPHY VERSUS CLINICAL EXAMINATION IN DETECTING MEIBOMIAN GLAND DYSFUNCTION (MGD) IN CHRONIC BLEPHARITIS
    SHIELDS, WJ
    STREET, DA
    JESTER, JV
    PETROLL, WM
    MATHERS, WD
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1991, 32 (04) : 1170 - 1170
  • [46] Therapeutic effectiveness of different machines in intense pulsed light treatment of meibomian gland dysfunction
    Qin, Zhenwei
    Zhu, Yirui
    Lu, Jiale
    Lin, Lin
    Huo, Yanan
    Wang, Haoyu
    Qiao, Chen
    Chen, Xiangxi
    Wu, Jianhua
    Zeng, Qingyan
    Jin, Xiuming
    ADVANCES IN OPHTHALMOLOGY PRACTICE AND RESEARCH, 2024, 4 (04): : 182 - 188
  • [47] Meibomian gland dysfunction
    Vanathi, Murugesan
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2025, 73 (02) : 155 - 156
  • [48] Meibomian gland dysfunction
    Driver, PJ
    Lemp, MA
    SURVEY OF OPHTHALMOLOGY, 1996, 40 (05) : 343 - 367
  • [49] Meibomian Gland Dysfunction
    Finis, D.
    Schrader, S.
    Geerling, G.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2012, 229 (05) : 506 - 513
  • [50] Intense pulsed light treatment and meibomian gland expression for moderate to advanced meibomian gland dysfunction
    Albietz, Julie M.
    Schmid, Katrina L.
    CLINICAL AND EXPERIMENTAL OPTOMETRY, 2018, 101 (01) : 23 - 33